News Date: Friday, March 29, 2019 - 09:15
The Center for Medicinal Cannabis Research (CMCR) is seeking to fund primary and pilot cannabis-related studies that further enhance the understanding of the efficacy and adverse effects of cannabis and cannabinoids as pharmacological agents for the treatment of medical and psychiatric disorders, and their potential public health impacts. Primary project awards will be up to $825,000 in total costs ($275,000 per year) for up to three years. Pilot awards will be up to $300,000 for two years (up to $165,000 in Year 1 and $135,000 in Year 2). Priority will be given to proposals addressing issues identified under Funding Priorities.
Letter of Intent Due: April 19, 2019 2 pm PST
Application Due: May 31, 2019 2 pm PST
Review: June 2019
Earliest Start Date: July 1, 2019
Funding priorities include studies that 1) provide proof-of-principle findings that inform future, more comprehensive studies, 2) address scientific gaps identified by authoritative reviews (e.g., ‘The Health Effects of Cannabis and Cannabinoids,’ National Academy of Sciences, Engineering, and Medicine; 2017), or 3) represent promising new directions for research. Studies may address both beneficial and harmful effects of cannabis (e.g., effects on cognition, driving).
Examples of areas of emphasis include, but are not limited to:
Applications will be submitted via proposalCENTRAL (https://proposalcentral.com/). Please review the attached RFA for instructions. Instructions and document templates can also be found on proposalCENTRAL. Search “CMCR Grants Program” to locate the application.
Center for Medicinal Cannabis Research (CMCR)
University of California, San Diego